Last reviewed · How we verify
Hydrogel vehicle
Hydrogel vehicle is a Small molecule drug developed by Derm Research, PLLC. It is currently FDA-approved for Topical drug delivery vehicle for dermatological applications.
A hydrogel vehicle serves as an inert pharmaceutical delivery matrix designed to control drug release and improve topical or local drug bioavailability.
A hydrogel vehicle serves as an inert pharmaceutical delivery matrix designed to control drug release and improve topical or local drug bioavailability. Used for Topical drug delivery vehicle for dermatological applications.
At a glance
| Generic name | Hydrogel vehicle |
|---|---|
| Sponsor | Derm Research, PLLC |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
Hydrogels are cross-linked polymer networks that absorb and retain water, creating a gel-like consistency. They function as passive delivery vehicles that can be formulated with active pharmaceutical ingredients to provide sustained or controlled release, improve skin penetration, and enhance patient compliance through improved formulation aesthetics and reduced irritation.
Approved indications
- Topical drug delivery vehicle for dermatological applications
Common side effects
Key clinical trials
- A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE) (PHASE3)
- Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema (PHASE1, PHASE2)
- Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers. (PHASE3)
- Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD. (PHASE2)
- Clinical Comparison of Xenograft With Hydrogel Versus Xenograft Alone in the Socket Preservation After Tooth Extraction: A Randomized Controlled Clinical Trial (PHASE3)
- Human Repeat Insult Patch Test of Wound Dressings (PHASE1)
- MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer (NA)
- Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hydrogel vehicle CI brief — competitive landscape report
- Hydrogel vehicle updates RSS · CI watch RSS
- Derm Research, PLLC portfolio CI
Frequently asked questions about Hydrogel vehicle
What is Hydrogel vehicle?
How does Hydrogel vehicle work?
What is Hydrogel vehicle used for?
Who makes Hydrogel vehicle?
What development phase is Hydrogel vehicle in?
Related
- Manufacturer: Derm Research, PLLC — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Topical drug delivery vehicle for dermatological applications
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing